Page 8 - Mikroscan Technologies Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mikroscan technologies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mikroscan Technologies Inc Today - Breaking & Trending Today

Digital Pathology Market Report Fundamental Growth Statistics and Top Competitors Analysis by: F. H


Search jobs
15-Apr-2021
Digital Pathology Market Report Fundamental Growth Statistics and Top Competitors Analysis by: F. Hoffmann-La Roche Ltd, Hamamatsu Photonics K.K., 3DHISTECH Ltd., AstraZeneca, GENERAL ELECTRIC, Healthcare Trading Co. LLC
The 
Digital pathology Market research report thoroughly explains each and every aspect related to the Global Digital pathology Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business. This report introduces manufacturing process analysis, market share of Digital pathology industry participants, and industry chain structure.
Digital pathology Market Insight:
Digital pathology market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 1,460.83 million by 2027 growing at a CAGR of 13.25% ....

United States , Hong Kong , United Kingdom , South Africa , Saudi Arabia , Vmscope Gmb , Hamamatsu Photonics , Asia Pacific , Leica Biosystems Nussloch Gmb , Koninklijke Philips , Ventana Medical Systems Inc , Optrascan Inc , Sunquest Information Systems Inc , Apollo Enterprise Imaging Corp , Dhistech Ltd , Perkinelmer Inc , Agfa Gevaert Group , Roche Ltd , Mikroscan Technologies Inc , Indica Labs Inc , Pixcelldata Ltd , General Electric , Research Methodology , Pathology Services , Company Profiles , Pathcore Inc ,

North America Digital Pathology Market Report 2021: Increasing Prevalence of Chronic Diseases / Higher Cost-Efficiency / Rapid Technological Advancement


Share this article
Share this article
ResearchAndMarkets.com s offering.
The North America digital pathology market size is expected to reach USD 593.9 million by 2028. The market is expected to expand at a CAGR of 6.5% from 2021 to 2028.
The market is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require data that facilitate personalizing therapy for patients. Hence, digital pathology is progressively being selected by pathologists as it has various benefits including accelerated diagnosis rate, diagnostic accuracy, and offers therapeutic recommendations to improve patient outcomes.
The growing number of collaborative agreements to develop as well as expedite the adoption of digital pathology in cancer diagnostics serves as a key growth factor contributing to the market. The use of artificial intelligence in digital pathology has gained momentum in the past ye ....

United States , Leica Biosystems , Laura Wood , Koninklijke Philips , Movement Analysis , Academic Research Institutes , Huron Technologies International Inc , Company Market Share Analysis , Application Movement Analysis , Roche Ltd , Hamamatsu Photonics Inc , Mikroscan Technologies Inc , Product Software , Office Hours Call , Research Methodology , Company Profiles , E St Office Hours Call , Research Methodology Scope , Inspirata Inc , Academic Research , Key Companies , Research Institutes , Public Companies , Olympus Corporation , Product Movement Analysis , Drug Discovery Development ,

Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights


Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights
News provided by
Share this article
SAN DIEGO, Feb. 25, 2021 /PRNewswire/
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced recent company highlights and financial results for the fourth quarter and full year ended December 31, 2020.
Over the last several months we achieved key clinical milestones, which provided the momentum for our successful raise of over $100 million. Together, these events have enabled us to accelerate the execution of our clinical programs and expand our pipeline to other relevant cancer indications, said Dr. Mark Erlander, chief executive officer of Cardiff Oncology. Data from our lead KRAS-mutate ....

United States , University Of Nebraska Medical Center , Karen Oshea , Mark Erlander , Vicki Kelemen , Joyce Allaire , American Society Of Hematology , Prostate Cancer Foundation Scientific , Lifesci Communications , Kansas University , Cardiff Oncology Inc , Network Development , Mikroscan Technologies Inc , Unetech Institute , Crc Program , Massachusetts Institute Of Technology , Drug Administration , Prnewswire Cardiff Oncology Inc , Afaxys Inc , Cancer Center , Perceptimed Inc , Exchange Commission , Crpc Program , Paradigm Diagnostics Inc , Norris Comprehensive Cancer Center , Mayo Clinic Cancer Centers Arizona ,